UNSPSC 41151619: Instrumentation for clinical multiplex test systems

In this classification Instrumentation for clinical multiplex test systems is a device intended to measure and sort multiple signals generated by an assay from a clinical sample. This instrumentation is used with a specific assay to measure multiple similar analytes that establish a single indicator to aid in diagnosis. Such instrumentation may be compatible with more than one specific assay.

The device includes a signal reader unit, and may also integrate reagent handling, hybridization, washing, dedicated instrument control, and other hardware components, as well as raw data storage mechanisms, data acquisition software, and software to process detected signals US FDA regulates Instrumentation for clinical multiplex test systems under 21 CFR 862.2570 and under FDA product code NSU.

UNSPSC 41151619 Instrumentation for clinical multiplex test systems, a Commodity code, shows minimal recent activity aligned with its nominal scope. State and local procurement under this code has not posted relevant opportunities in the dataset; the single state-local opportunity tagged to this code—Harris County, Texas requesting a unit dose packaging system under RFP due October 19, 2026—falls outside clinical multiplex instrumentation and lacks sufficient detail to characterize the issuing body's actual need. The code's abstract definition does not match observable recent state-local buying patterns in the source material.

The source records heavy activity by Mississippi State University, the University of Mississippi, the University of Wisconsin-Madison, and other academic research institutions, but their recent solicitations target specialized research equipment—dynamic mechanical analyzers, X-ray diffractometers, gas cluster ion beam systems, induction melting furnaces, cold spray additive manufacturing, and acoustic telemetry receivers—none of which fit the clinical multiplex test-systems category. Regional and state health agencies (Illinois State Police Department of Forensic Services, Texas Health and Human Services Commission, Escambia County, and Oregon DCBS) have posted opportunities for laboratory and environmental testing supplies and equipment, but these address water quality, bacterial detection, and forensic DNA analysis rather than clinical multiplex diagnostics. Without documented recent state-local opportunities actually purchasing clinical multiplex instrumentation, the code presents no actionable signal for business development targeting state or local procurement activity.